Oncogene - Table of Contents alert Volume 31 Issue 2

TABLE OF CONTENTS Volume 31, Issue 2 (January 2012) In this issue Original Articles Letter to the Editor Response to Letter to the Editor Also new AOP Advertisment The Novel Cytotoxic Drugs meeting explores the discovery and development of soluble, stable and potent anti-cancer drugs. Bringing together pharma, biotechs, academic leaders, as well as contract manufacturers and handling experts, this meeting will provide an unbeatable opportunity to benchmark your company against leaders in the cytotoxic field Register Now Download the Brochure Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement New: Cancer Sequencing Service for paired tumor/normal samples Make use of paired tumor/normal samples for your NGS projects by using Complete Genomics' new Cancer Sequencing Service. Listen to Dr. Sharoni Jacobs, Senior Product Manager, explain how the complexities of heterogeneous samples are addressed and describes the data results customer receive from the advanced algorithms in our analysis pipeline.   Original Articles Top Disruption of Tacc3 function leads to in vivo tumor regression R Yao, Y Natsume, Y Saiki, H Shioya, K Takeuchi, T Yamori, H Toki, I Aoki, T Saga and T Noda Oncogene 2012 31: 135-148; advance online publication, June 20, 2011; 10.1038/onc.2011.235 Abstract | Full Text Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells L Y W Bourguignon, C Earle, G Wong, C C Spevak and K Krueger Oncogene 2012 31: 149-160; advance online publication, June 20, 2011; 10.1038/onc.2011.222 Abstract | Full Text Inflammatory signaling compromises cell responses to interferon alpha W-C HuangFu, J Qian, C Liu, J Liu, A E Lokshin, D P Baker, H Rui and S Y Fuchs Oncogene 2012 31: 161-172; advance online publication, June 13, 2011; 10.1038/onc.2011.221 Abstract | Full Text Restoration of tumor suppressor p53 by differentially regulating pro- and anti-p53 networks in HPV-18-infected cervical cancer cells B Saha, A Adhikary, P Ray, S Saha, S Chakraborty, S Mohanty, K Das, S Mukherjee, M Mazumdar, L Lahiri, D M S Hossain, G Sa and T Das Oncogene 2012 31: 173-186; advance online publication, July 18, 2011; 10.1038/onc.2011.234 Abstract | Full Text Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells X Wang, C Venugopal, B Manoranjan, N McFarlane, E O'Farrell, S Nolte, T Gunnarsson, R Hollenberg, J Kwiecien, P Northcott, M D Taylor, C Hawkins and S K Singh Oncogene 2012 31: 187-199; advance online publication, June 20, 2011; 10.1038/onc.2011.232 Abstract | Full Text TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling A Fiorio Pla, H L Ong, K T Cheng, A Brossa, B Bussolati, T Lockwich, B Paria, L Munaron and I S Ambudkar Oncogene 2012 31: 200-212; advance online publication, June 20, 2011; 10.1038/onc.2011.231 Abstract | Full Text Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer G S Coombs, A A Schmitt, C A Canning, A Alok, I C C Low, N Banerjee, S Kaur, V Utomo, C M Jones, S Pervaiz, E J Toone and D M Virshup Oncogene 2012 31: 213-225; advance online publication, June 13, 2011; 10.1038/onc.2011.228 Abstract | Full Text Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma S-S Lo, P-S Hung, J-H Chen, H-F Tu, W-L Fang, C-Y Chen, W-T Chen, N-R Gong and C-W Wu Oncogene 2012 31: 226-237; advance online publication, June 13, 2011; 10.1038/onc.2011.226 Abstract | Full Text Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP L Angus, S Moleirinho, L Herron, A Sinha, X Zhang, M Niestrata, K Dholakia, M B Prystowsky, K F Harvey, P A Reynolds and F J Gunn-Moore Oncogene 2012 31: 238-250; advance online publication, June 13, 2011; 10.1038/onc.2011.224 Abstract | Full Text NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699 J E Hunter, E Willmore, J A E Irving, Z Hostomsky, S J Veuger and B W Durkacz Oncogene 2012 31: 251-264; advance online publication, June 27, 2011; 10.1038/onc.2011.229 Abstract | Full Text Letter to the Editor Top Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanisms K R Doyle, M A Mitchell, C L Roberts, S James, J E Johnson, Y Zhou, M von Mehren, D Lev, D Kipling and D Broccoli Oncogene 2012 31: 265-266; advance online publication, June 27, 2011; 10.1038/onc.2011.225 Full Text Response to Letter to the Editor Top Response to ‘Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanisms’ W N Keith, K Lafferty-Whyte, C J Cairney, N Zaffaroni and A Bilsland Oncogene 2012 31: 267-268; advance online publication, August 29, 2011; 10.1038/onc.2011.374 Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.